1st Annual LIVE Medical Crossfire: Expert Exchanges in Hematologic Malignancies
Webcast
OVERVIEW
1st Annual LIVE Medical Crossfire: Expert Exchanges in Hematologic Malignancies is organized by Physicians Education Resource, LLC (PER) and will be held during Sep 30, 2017 - Sep 30, 2018.
The target audience for this medical event is oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cancer are also invited to participate. This CME Conference has been approved for a maximum of 8.00 AMA PRA Category 1 Credits.
Conference Overview :
This one day conference is designed to discuss some of the hottest clinical issues in the management of hematologic malignancies. The meeting is designed to facilitate the practical application of emerging data key to treating various forms of cancer, provide participants with the information they need to inform clinical decision making that allows for personalized approaches, and will ensure participants have the ability to safely apply novel strategies to real-world clinical case scenarios they routinely encounter in their practices.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe major clinically unmet needs in the management of hematologic malignancies
• Explain clinical trial findings that inform decision-making concerning the management of hematologic malignancies
• Detail proactive methods to mitigate and manage the impact of treatment-related toxicities associated with novel targeted and immunotherapeutic approaches
• Place emerging data sets in the context of evolving treatment paradigms in the management of leukemias, lymphomas, and multiple myeloma
Additional details will be posted as soon as they are available.
The target audience for this medical event is oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cancer are also invited to participate. This CME Conference has been approved for a maximum of 8.00 AMA PRA Category 1 Credits.
Conference Overview :
This one day conference is designed to discuss some of the hottest clinical issues in the management of hematologic malignancies. The meeting is designed to facilitate the practical application of emerging data key to treating various forms of cancer, provide participants with the information they need to inform clinical decision making that allows for personalized approaches, and will ensure participants have the ability to safely apply novel strategies to real-world clinical case scenarios they routinely encounter in their practices.
Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe major clinically unmet needs in the management of hematologic malignancies
• Explain clinical trial findings that inform decision-making concerning the management of hematologic malignancies
• Detail proactive methods to mitigate and manage the impact of treatment-related toxicities associated with novel targeted and immunotherapeutic approaches
• Place emerging data sets in the context of evolving treatment paradigms in the management of leukemias, lymphomas, and multiple myeloma
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyHaematology
Quick Links